🇺🇸 FDA

Intelligence Platform

Patents

Browse 225 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8524482

Method and system for sampling and separating submicron-sized particles based on density a

The United States of America as represented by the Secretary of the Army · Granted Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8513005

DNA immunogenic composition comprising a full-length modified poxvirus L1R gene fused to a

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8501926

Malaria vaccine

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8492428

Small-molecule botulinum toxin inhibitors

The United States of America as represented by the Secretary of the Army · Granted Tue Jul 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8431176

Liquid chromatographic fraction of enzymatically polymerized flavonoid as an antioxidant

The United States of America as represented by the Secretary of the Army · Granted Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8354390

Compositions and methods for inhibiting expression of a gene from the ebola virus

The United States of America as represented by the Secretary of the Army · Granted Tue Jan 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8298546

Isolation and purification of P. falciparum merozoite protein-142 vaccine

The United States of America as represented by the Secretary of the Army · Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8283370

Imidazolidinedione derivatives as antimalarial agents, preparation thereof, and methods of

The United States of America as represented by the Secretary of the Army · Granted Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8268615

Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypep

The United States of America as represented by the Secretary of the Army · Granted Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8258280

Plasmodium vivax hybrid circumsporozoite protein and vaccine

The United States of America as represented by the Secretary of the Army · Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8211447

Recombinant P. falciparum merozoite protein-142 vaccine

The United States of America as represented by the Secretary of the Army · Granted Tue Jul 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8183358

Puumala virus full-length M segment-based DNA vaccines

The United States of America as represented by the Secretary of the Army · Granted Tue May 22 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8143308

Synthesis of oligo/poly(catechins) and methods of use

The United States of America as represented by the Secretary of the Army · Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8110354

Use of Shigella invaplex to transport functional proteins and transcriptionally active nuc

The United States of America as represented by the Secretary of the Army · Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8067202

Bacterial superantigen vaccines

The United States of America as represented by the Secretary of the Army · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8030287

DNA vaccine against North American spring viremia of carp virus

The United States of America as represented by the Secretary of the Army · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8012493

Malaria vaccines

The United States of America as represented by the Secretary of the Army · Granted Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7999001

Antiviral compounds and methods of using thereof

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7976832

Active topical skin protectants containing amines, polyalkenimines and /or derivatives

The United States of America as represented by the Secretary of the Army · Granted Tue Jul 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7973020

Compositions and methods for inhibiting expression of a gene from the ebola virus

The United States of America as represented by the Secretary of the Army · Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7956086

Methods for the formulation and manufacture of artesunic acid for injection

The United States of America as represented by the Secretary of the Army · Granted Tue Jun 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7943148

Amino acid sites in Flavivirus E proteins useful for development of diagnostics and vaccin

The United States of America as represented by the Secretary of the Army · Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7931919

Method of producing glycine-stabilized, lyophilized plasma

The United States of America as represented by the Secretary of the Army · Granted Tue Apr 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7867983

Methods to protect skeletal muscle against injury

The United States of America as represented by the Secretary of the Army · Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted